Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Fangxia Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1737-4204; OpenAlex author ID A5023386987. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 3 papers

Papers 4

  1. Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217523↗
  2. N-acetyltransferase 10 Promotes Pancreatic Cancer Progression Through ZEB1/MT1-MMP Axis. Co-author DOI 10.1097/mpa.0000000000002492↗
  3. ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16. Co-author DOI 10.1172/jci195970↗
  4. Protocadherin-1 serves as a prognostic biomarker and promotes pancreatic cancer progression by suppressing CD8+ T cell infiltration through CCL5-CCR5 axis. Co-author PMID 38058826↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaobo Zhang · 4 shared papers, 2023–2025 · strength 0.88
  2. Yumeng Hu · 3 shared papers, 2025 · strength 0.71
  3. Mingyang Liu · 3 shared papers, 2025 · strength 0.71
  4. Zhijun Zhou · 1 shared paper, 2025 · strength 0.22
  5. Min Li · 1 shared paper, 2025 · strength 0.22
  6. Haoran Qi · 1 shared paper, 2025 · strength 0.22
  7. Wenming Wu · 1 shared paper, 2025 · strength 0.22
  8. Zhihua Liu · 1 shared paper, 2025 · strength 0.22
  9. Yongxing Du · 1 shared paper, 2025 · strength 0.22
  10. Jingyong Xu · 1 shared paper, 2025 · strength 0.22
  11. Hui‐Ju Wang · 1 shared paper, 2023 · strength 0.17
  12. Xiaohao Zheng · 1 shared paper, 2023 · strength 0.17
  13. Zhichen Jiang · 1 shared paper, 2023 · strength 0.17
  14. Mingyang Liu · 1 shared paper, 2023 · strength 0.17
  15. Weiwei Jin · 1 shared paper, 2023 · strength 0.17
  16. Yiping Mou · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.